CA1167278A - Epreuve de separation des fractions d'hemoglobine glycosilatees - Google Patents
Epreuve de separation des fractions d'hemoglobine glycosilateesInfo
- Publication number
- CA1167278A CA1167278A CA000400444A CA400444A CA1167278A CA 1167278 A CA1167278 A CA 1167278A CA 000400444 A CA000400444 A CA 000400444A CA 400444 A CA400444 A CA 400444A CA 1167278 A CA1167278 A CA 1167278A
- Authority
- CA
- Canada
- Prior art keywords
- amino acid
- ampholyte
- test kit
- polypeptide
- separator composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000001554 Hemoglobins Human genes 0.000 title claims abstract description 38
- 108010054147 Hemoglobins Proteins 0.000 title claims abstract description 38
- INGWEZCOABYORO-UHFFFAOYSA-N 2-(furan-2-yl)-7-methyl-1h-1,8-naphthyridin-4-one Chemical compound N=1C2=NC(C)=CC=C2C(O)=CC=1C1=CC=CO1 INGWEZCOABYORO-UHFFFAOYSA-N 0.000 title claims abstract description 28
- 238000012360 testing method Methods 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 49
- 239000000872 buffer Substances 0.000 claims abstract description 36
- 239000000203 mixture Substances 0.000 claims abstract description 28
- 102000017011 Glycated Hemoglobin A Human genes 0.000 claims abstract description 8
- 108010014663 Glycated Hemoglobin A Proteins 0.000 claims abstract description 8
- 238000013375 chromatographic separation Methods 0.000 claims abstract description 8
- 238000005342 ion exchange Methods 0.000 claims abstract description 8
- 238000004587 chromatography analysis Methods 0.000 claims abstract description 6
- 150000001413 amino acids Chemical class 0.000 claims description 34
- 229940024606 amino acid Drugs 0.000 claims description 33
- 235000001014 amino acid Nutrition 0.000 claims description 33
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 22
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 22
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 22
- 229920001184 polypeptide Polymers 0.000 claims description 18
- 239000008280 blood Substances 0.000 claims description 17
- 210000004369 blood Anatomy 0.000 claims description 17
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical group [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 claims description 14
- 239000004471 Glycine Substances 0.000 claims description 11
- 229960002449 glycine Drugs 0.000 claims description 9
- 238000010828 elution Methods 0.000 claims description 8
- 108010008488 Glycylglycine Proteins 0.000 claims description 7
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 7
- 230000002378 acidificating effect Effects 0.000 claims description 7
- 229960003767 alanine Drugs 0.000 claims description 7
- 235000004279 alanine Nutrition 0.000 claims description 7
- 229940043257 glycylglycine Drugs 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 6
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 3
- 230000006872 improvement Effects 0.000 claims description 3
- 239000004474 valine Substances 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims description 2
- 238000003556 assay Methods 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 3
- 238000000926 separation method Methods 0.000 abstract description 3
- -1 hemoglobins Chemical class 0.000 abstract description 2
- 230000003455 independent Effects 0.000 abstract 1
- 239000011347 resin Substances 0.000 description 8
- 229920005989 resin Polymers 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 229910014033 C-OH Inorganic materials 0.000 description 4
- 229910014570 C—OH Inorganic materials 0.000 description 4
- 125000002091 cationic group Chemical group 0.000 description 4
- 239000000306 component Substances 0.000 description 4
- 239000012064 sodium phosphate buffer Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003729 cation exchange resin Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical compound CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000002934 lysing effect Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
- DSMRYCOTKWYTRF-UHFFFAOYSA-N 3-methylfuran-2-carbaldehyde Chemical compound CC=1C=COC=1C=O DSMRYCOTKWYTRF-UHFFFAOYSA-N 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000004705 aldimines Chemical class 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 229950010030 dl-alanine Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 102000018146 globin Human genes 0.000 description 1
- 108060003196 globin Proteins 0.000 description 1
- 230000004190 glucose uptake Effects 0.000 description 1
- 230000002414 glycolytic effect Effects 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- ODUCDPQEXGNKDN-UHFFFAOYSA-N nitroxyl Chemical group O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960003339 sodium phosphate Drugs 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000400444A CA1167278A (fr) | 1982-04-05 | 1982-04-05 | Epreuve de separation des fractions d'hemoglobine glycosilatees |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000400444A CA1167278A (fr) | 1982-04-05 | 1982-04-05 | Epreuve de separation des fractions d'hemoglobine glycosilatees |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1167278A true CA1167278A (fr) | 1984-05-15 |
Family
ID=4122509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000400444A Expired CA1167278A (fr) | 1982-04-05 | 1982-04-05 | Epreuve de separation des fractions d'hemoglobine glycosilatees |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA1167278A (fr) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4879039A (en) * | 1986-07-30 | 1989-11-07 | Toyo Soda Manufacturing Co., Ltd. | Process for measuring stable-type glycated hemoglobin in a sample |
| US5730867A (en) * | 1988-06-10 | 1998-03-24 | Drew; Keith Raymond | Method and apparatus for low pressure liquid chromatography |
| US5807747A (en) * | 1989-06-13 | 1998-09-15 | Clinical Innovations Limited | Method and apparatus for determination of glycosylated protein |
| CN113009021A (zh) * | 2018-12-29 | 2021-06-22 | 江山德瑞医疗科技有限公司 | 一种添加剂在测定糖化血红蛋白中的使用方法 |
-
1982
- 1982-04-05 CA CA000400444A patent/CA1167278A/fr not_active Expired
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4879039A (en) * | 1986-07-30 | 1989-11-07 | Toyo Soda Manufacturing Co., Ltd. | Process for measuring stable-type glycated hemoglobin in a sample |
| US5004546A (en) * | 1986-07-30 | 1991-04-02 | Toyo Soda Manufacturing Co., Ltd. | Process for measuring stable-type glycated hemoglobin in a sample |
| US5730867A (en) * | 1988-06-10 | 1998-03-24 | Drew; Keith Raymond | Method and apparatus for low pressure liquid chromatography |
| US5807747A (en) * | 1989-06-13 | 1998-09-15 | Clinical Innovations Limited | Method and apparatus for determination of glycosylated protein |
| CN113009021A (zh) * | 2018-12-29 | 2021-06-22 | 江山德瑞医疗科技有限公司 | 一种添加剂在测定糖化血红蛋白中的使用方法 |
| CN113009021B (zh) * | 2018-12-29 | 2023-04-14 | 江山德瑞医疗科技有限公司 | 一种添加剂在测定糖化血红蛋白中的使用方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Eross et al. | Colorimetric measurement of glycosylated protein in whole blood, red blood cells, plasma and dried blood | |
| Ellis et al. | An automated" high-pressure" liquid-chromatographic assay for hemoglobin A1c. | |
| Peacock | Glycosylated haemoglobin: measurement and clinical use. | |
| John | Glycated haemoglobin analysis | |
| Austin et al. | Non-enzymic glycation of individual plasma proteins in normoglycemic and hyperglycemic patients. | |
| Yue et al. | The measurement of glycosylated hemoglobin in man and animals by aminophenylboronic acid affinity chromatography | |
| Middle et al. | Separation of glycosylated haemoglobins using immobilized phenylboronic acid. Effect of ligand concentration, column operating conditions, and comparison with ion-exchange and isoelectric-focusing | |
| Spicer et al. | A simplified assay of hemoglobin AIc in diabetic patients by use of isoelectric focusing and quantitative microdensitometry | |
| US6309887B1 (en) | Filter paper treatment for improved diagnostic assays | |
| JPH06508690A (ja) | グリコヘモグロビンの迅速測定 | |
| US4407961A (en) | Ion-exchange system and method for isolation and determination of glycosylated hemoglobin in human blood | |
| Chang et al. | Evaluation and interference study of hemoglobin A1c measured by turbidimetric inhibition immunoassay | |
| Little et al. | Interlaboratory comparison of glycohemoglobin results: College of American Pathologists survey data | |
| Jaynes et al. | Evaluation of a mini-column chromatographic procedure for the measurement of hemoglobin A1c | |
| JPH05133938A (ja) | アガロースゲル電気泳動によるグリコシル化ヘモグロビンＨｂ Ａｌｃの分離法 | |
| JP2782470B2 (ja) | グリコヘモグロビンの分離方法および分離装置並びに分離カラム | |
| CA1120389A (fr) | Methode de dosage des hormones libres dans les liquides biologiques | |
| CA1167278A (fr) | Epreuve de separation des fractions d'hemoglobine glycosilatees | |
| US4649122A (en) | Means for determining percentage of glycohemoglobin in whole blood | |
| Goldstein et al. | Recent advances in glycosylated hemoglobin measurements | |
| Little et al. | Endocrine (standardization of glycohemoglobin measurement) | |
| EP0576625B1 (fr) | Procede pour analyser la glyceration de l'hemoglobine | |
| Talwar et al. | Determination of glycosylated adult and foetal haemoglobins by affinity chromatography | |
| Winterhalter | [44] Determination of glycosylated hemoglobins | |
| EP0090868A1 (fr) | Détermination des hémoglobines glycosylées |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry | ||
| MKEX | Expiry |
Effective date: 20010515 |